{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:16:25Z","timestamp":1784081785183,"version":"3.55.0"},"reference-count":51,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS | Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2016-I2M-3-021"],"award-info":[{"award-number":["2016-I2M-3-021"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI084048"],"award-info":[{"award-number":["AI084048"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["AI116969"],"award-info":[{"award-number":["AI116969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2022,5,17]]},"abstract":"<jats:p>\n                    <jats:named-content content-type=\"genus-species\">Neisseria gonorrhoeae<\/jats:named-content>\n                    isolates collected in Nanjing, China, that possessed decreased susceptibility (or resistance) to extended-spectrum cephalosporins (ESCs) were examined for susceptibility to ertapenem, and their sequence types were determined. Ceftriaxone and cefixime MICs\u2009of \u22650.125\u2009mg\/L and\u2009\u22650.25\u2009mg\/L, respectively, were first determined in 259 strains isolated between 2013 and 2019, and then MICs of ertapenem were measured using the antimicrobial gradient Epsilometer test (Etest).\n                  <\/jats:p>","DOI":"10.1128\/aac.00109-22","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T04:31:07Z","timestamp":1651465867000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["<i>In Vitro<\/i>\n                    Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019)"],"prefix":"10.1128","volume":"66","author":[{"given":"Xuechun","family":"Li","sequence":"first","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Le","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdi","family":"Lou","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7772-4216","authenticated-orcid":true,"given":"Caroline A.","family":"Genco","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Medicine, Tufts University, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Rice","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2053-7070","authenticated-orcid":true,"given":"Xiaohong","family":"Su","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Report on global sexually transmitted infection surveillance -2018.","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. 2018. Report on global sexually transmitted infection surveillance -2018. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/JD9.0000000000000008"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks162"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30310-9"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002344"},{"key":"e_1_3_2_9_2","volume-title":"WHO guidelines for the treatment of Neisseria gonorrhoeae.","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. WHO guidelines for the treatment of Neisseria gonorrhoeae. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00010-14"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6950a6"},{"key":"e_1_3_2_12_2","volume-title":"Sexually transmitted disease surveillance 2018.","author":"CDC","year":"2019","unstructured":"CDC. 2019. Sexually transmitted disease surveillance 2018. CDC, US Department of Health and Human Services, Atlanta, GA."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq289"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2294"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.supplement_1.s47"},{"key":"e_1_3_2_16_2","volume-title":"Key findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) 2017.","author":"Public Health England","year":"2018","unstructured":"Public Health England. 2018. Key findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) 2017. Public Health England, London, United Kingdom."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1512757"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462419886775"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002499"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2507.190172"},{"key":"e_1_3_2_22_2","first-page":"168","article-title":"Guidelines for diagnosis and treatment of syphilis, gonorrhea and genital Chlamydia trachomatis infection (2020)","volume":"53","author":"National Center for STD Control, Chinese Center for Disease Control and Prevention; Venereology Group, Chinese Society of Dermatology; Subcommittee on Venereology, China Dermatologist Association","year":"2020","unstructured":"National Center for STD Control, Chinese Center for Disease Control and Prevention; Venereology Group, Chinese Society of Dermatology; Subcommittee on Venereology, China Dermatologist Association. 2020. Guidelines for diagnosis and treatment of syphilis, gonorrhea and genital Chlamydia trachomatis infection (2020). Chin J Dermatol 53:168\u2013179.","journal-title":"Chin J Dermatol"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656561003631397"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.08.005"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.2.237"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00625-3"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00326-12"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.045377"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","unstructured":"Ison CA Hussey J Sankar KN Evans J Alexander S. 2011. Gonorrhoea treatment failures to cefixime and azithromycin in England 2010. Euro Surveill 16:19833. https:\/\/www.eurosurveillance.org\/content\/10.2807\/ese.16.14.19833-en.","DOI":"10.2807\/ese.16.14.19833-en"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01604-06"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00304-09"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S335252"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt537"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh272"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3203-3206.2004"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01591-05"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02143-08"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.11.003"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab091"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02281-18"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02313-18"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.029694"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051229"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks036"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.08.015"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.66.6.453"},{"key":"e_1_3_2_47_2","first-page":"21","volume-title":"Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus.","author":"Unemo M","year":"2013","unstructured":"Unemo M, Ison C. 2013. Gonorrhoea, p 21\u201354. In Unemo M, Ballard R, Ison C, Lewis D, Ndowa F, Peeling R (ed), Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_48_2","volume-title":"Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI document M100-S22.","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing; 22nd informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_49_2","volume-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae.","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_50_2","unstructured":"Liofilchem. 2021. MIC test strip technical sheet Gonococci. Liofilchem Roseto degli Abruzzi Italy. https:\/\/www.liofilchem.com\/images\/brochure\/mic_test_strip_patent\/MTS13.pdf."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00100-17"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1086\/383047"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00109-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00109-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T09:08:21Z","timestamp":1652778501000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00109-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,17]]}},"alternative-id":["10.1128\/aac.00109-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.00109-22","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.25.477800","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"2022-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00109-22"}}